Stock News - Trevi Therapeutics, Inc. $TRVI

Latest Stock News for $TRVI
Trevi Therapeutics Reports Q4 and Full Year 2025 Financial Results, Plans Phase 3 Trials

Expected Stock impact: Noticeably Positive
2026-03-17 20:21:16